Studies on the expression profiles of CASZ1 in a variety of solid tumors have revealed low expression in neuroblastoma and hepatocellular carcinoma and high expression in malignancies such as epithelial ovarian cancer21–23. This evidence concerns the gene CASZ1 and neuroblastoma.